Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay

Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered <italic>In Vivo</italic><xref ref-type="fn" rid="FN2">2</xref>

1966 • 537 citations

Statistics with applications to the biological and health sciences

1970 • 491 citations

Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy

1981 • 378 citations

Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

1970 • 285 citations

Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

1969 • 216 citations

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

1978 • 166 citations

IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPY

1980 • 165 citations

Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion

1977 • 125 citations

Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213.

1976 • 102 citations

Pharmacologic studies of anticancer drugs with the human tumor stem cell assay

1981 • 79 citations

ARE CELL KINETIC DATA RELEVANT FOR THE DESIGN OF TUMOUR CHEMOTHERAPY SCHEDULES?*

1974 • 67 citations

Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone

1982 • 64 citations

Clinical correlations of in vitro drug sensitivity.

1980 • 62 citations

In vitro evaluation of anticancer drugs with the human tumor stem cell assay.

1981 • 60 citations

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).

1981 • 45 citations

In vitro drug assay: pharmacologic considerations.

1980 • 43 citations

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.

1982 • 32 citations

Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells

1983 • 19 citations

Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay

1984 • 17 citations

Definition of the Cell Cycle Segment with Special Sensitivity to Vinblastine

1978 • 15 citations

Cited By (0)

Loading...